Saptarsi Haldar, MD
Associate Investigator, Gladstone Institute of Cardiovascular Disease

Other Professional Titles

Associate Professor, Department of Medicine, University of California, San Francisco
Faculty, Cardiovascular Research Institute (CVRI), University of California, San Francisco
Faculty, Biomedical Sciences (BMS) Graduate Program, University of California, San Francisco


(415) 734-4058


(415) 355-0960


Sue Cammack
(415) 734-4806

On The Web


Dr. Saptarsi Haldar’s research focuses on how cells in the cardiovascular system control gene expression and how these gene control mechanisms go awry during disease. His lab has a major interest in congestive heart failure, a very common and deadly condition that affects a large number of adults. More specifically, he has developed therapeutic approaches that target gene-control mechanisms in the stressed and failing heart, a process that has striking similarities to uncontrolled growth in cancers.

Dr. Haldar has received several awards, including the NASA Award in Biomechanics Research, a Stanley J. Sarnoff Fellowship for Cardiovascular Science, the Jeremiah Stamler Distinguished Young Investigator Award, and the Hartwell Foundation Individual Biomedical Research Award. He was also a member of the Associate Scientific Advisory Board of Science Translational Medicine and has served on grant reviews for the National Institutes of Health and American Heart Association. 


Dr. Haldar received a bachelor’s dgree in engineering from Cornell University and an MD from Johns Hopkins University School of Medicine. He completed an internship and residency in internal medicine at Johns Hopkins and a fellowship in cardiovascular disease at Brigham & Women’s Hospital and Harvard Medical School. He is a board-certified cardiologist. 

Why Gladstone

I have always known about Gladstone because of the pioneering discoveries published by the scientists here. My interests in cardiovascular epigenetics and heart failure pathobiology synergize with the research themes of all three Institutes. In my personal meetings with Gladstone investigators, staff, and leadership, I was immediately drawn to the collegial spirit and culture of integrity and excellence that permeate the organization. I was particularly excited about joining a forward-thinking and nimble organization that embraces collaboration and teamwork to tackle some of the biggest challenges in contemporary biomedicine.